The estrogen coactivator AIB1 (SRC3) in combination with HER-2 is a prognostic and predictive marker in patients with breast cancer. - Osborne,CK.; Bardou,V-J.; Hilsenbeck,SG. (Proc Am Soc Clin Oncol, 2002)